BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism.

ABSTRACT:

Background

Helicobacter pylori (H. pylori) is the main pathogen that causes a variety of upper digestive diseases. The drug resistance rate of H. pylori is increasingly higher, and the eradication rate is increasingly lower. The antimicrobial resistance of H. pylori is an urgent global problem. It has been confirmed that Banxia Xiexin decoction (BXXXT) demonstrates the effects of treating gastrointestinal diseases, inhibiting H. pylori and protecting gastric mucosa. The purpose of the present study is to further explore the therapeutic effects of BXXXT on drug-resistant H. pylori.

Aim

To confirm that BXXXT demonstrates therapeutical effects in vivo and in vitro on gastritis mice with drug-resistant H. pylori and

SUBMITTER: Li XH 

PROVIDER: S-EPMC10237109 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature